ASCO meeting showcased some of the latest developments in the cancer research with AstraZeneca (AZN) headlining the event.
Mayo Clinic on MSN4h
COVID-19 drugs: Are there any that work?Answer Section COVID-19 medicine can help people who are at risk of, diagnosed with, or have symptoms of coronavirus disease 2019 (COVID-19). The medicine helps manage symptoms, stop the virus that ...
SpringWorks Therapeutics (NASDAQ:SWTX) announced on Friday evening that its partner GSK (NYSE:GSK) has notified its decision ...
Cruz, MD, discussed data from the KarMMa-3 trial of idecabtagene vicleucel and real-world data on the CAR T-cell therapy in ...
While previous studies have shown that antibody responses to one EBV protein -- EBNA1 -- also recognise a small number of proteins of the central nervous system, this study found that T-cells, another ...
In the ongoing Omicron era, a new COVID-19 antibody could renew optimism for urgently required SARS-CoV-2 monoclonal ...
Respiratory syncytial virus (RSV) hospitalization–related features may help inform prevention approaches among children with ...
A study finds 1 year of avelumab treatment improves distant disease free and overall survival rates in patients with early ...
Eli Lilly is pursuing traditional approval for its anti-amyloid Alzheimer's disease drug, but the FDA is seeking input on how ...
A small retrospective study found that combining obinutuzumab with radiation therapy may offer a viable and well-tolerated ...
Ipsen is hot on Marengo Therapeutics’ ability to treat “cold” tumors. | Ipsen is hot on Marengo Therapeutics’ ability to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback